American Re, an arm of No 1 reinsurer Munich Re, is receiving a $2 billion funds transfusion to keep its reserves healthy. It’s estimated that will cover the high claims AmRe has experienced.

Adding to its troubles, the reinsurer has indicated that it may not reach its 2002 profit target because of the weak capital markets.